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aBstraCt
BaCkground: Orbital adenocarcinoma usually is metastatic and rarely can be primary disease of the orbit with no 
clear standard of care. Herein, we report a case of primary apocrine adenocarcinoma in the orbit with invasion into 
lacrimal sac in a young patient.
Case report: A 38-year-old male presented with enlarging lump in the left eye. Ocular imaging studies showed 
an orbital mass with invasion into the lacrimal sac and surrounding muscles. The lesion was found to be adeno-
carcinoma with apocrine differentiation in both pathology and immunohistochemistry. Full body imaging studies 
showed no extra ocular spread and no other tumors to suggest orbital metastasis. The patient was treated with orbital 
exenteration and was given adjuvant local radiotherapy and systemic chemotherapy because of positive margins and 
high risk pathological features. On serial exams over 5 years follow up, the patient was free of local recurrence or 
distant metastasis.
ConClusion: Orbital adenocarcinoma can present as a primary orbital tumor in young adults originating from 
apocrine glands, and aggressive surgical resection can be lifesaving management.
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introduCtion
There are two types of sweat glands: apocrine 
and eccrine. Unlike eccrine glands, apocrine glands 
are distributed in limited areas in the body includ-
ing the axilla, anogenital areas, mammary glands, 
and eyelids [1]. Characteristically, these glands se-
crete by decapitation; part of the cytoplasm of the 
glandular cell is pushed off into the glandular lu-
men [2]. The glands of Moll are modified apocrine 
glands that lie in the base of the follicles of the 
eyelashes [3]. 
Adenocarcinoma (AC) is a rare, slow-growing 
skin carcinoma with apocrine differentiation aris-
ing from apocrine glands. This is rarely seen in the 
orbit, but common in the axilla and the anogenital 
region [4]. Adenocarcinoma in the orbit is usually 
metastasis from breast or lung adenocarcinoma, but 
can be rarely primary in the ocular region, where 
they are usually derived from Moll glands of the 
eyelid [5]. Adenocarcinoma should be recognized 
and treated properly because of a high rate of both 
local recurrence and distant metastasis [6]. Herein 
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we are reporting an extremely rare case of primary 
orbital adenocarcinoma in a young patient who was 
cured by orbital exenteration.
Case report
A 38-year-old previously healthy male patient 
referred to the ophthalmology department at King 
Hussein Cancer Centre (KHCC) with a slowly-en-
larging, painless lump in the medial corner of the 
left eye of four months duration. On clinical ex-
amination, best corrected visual acuity was 20/20 in 
both eyes. A mass overlying the left caruncle was 
grossly visible. It was not attached to eyelids. Motil-
ity testing revealed a limitation of abduction in the 
left eye. This was associated with binocular diplopia 
on left gaze. Hertel exophthalmometry showed no 
proptosis. Slit-lamp examination of both the anteri-
or and posterior segments was normal. Examination 
of the right eye was unremarkable. Intraocular pres-
sure was normal in both eyes. Palpation of regional 
lymph nodes showed no palpable preauricular, sub-
mandibular or cervical nodes.
Orbital magnetic resonance imaging (MRI) with 
contrast was requested. It showed an intensely en-
hancing mass involving the anterior aspect of the 
left orbit medially. It measured 2.3 × 1.1 centim-
eters (cm) in the axial plane. The mass was invading 
the lacrimal sac and the upper part of the left nasol-
acrimal duct. It abutted the anterior eye globe, me-
dial rectus, and inferior oblique muscles. The mass 
was inseparable from the overlying skin but was not 
arising from the skin (Fig. 1). Orbital computed 
tomography CT scan with contrast showed focal 
destruction of the lacrimal bone (Fig. 2).
Systemic staging including a whole body CT 
scan did not reveal any tumors elsewhere. A bone 
scan was done and it showed no convincing evi-
dence of osteoblastic metastases. No tumorous le-
sions suggestive of primary apocrine adenocarcino-
ma were found elsewhere in the skin, particularly in 
axillae or around the nipples. Incisional biopsy for 
the left orbital mass was undertaken. The pathology 
examination revealed a moderately differentiated 
apocrine adenocarcinoma (Fig. 3).
On immunohistochemistry, tumor cells were 
positive for androgen receptor (AR), cytokera-
tin 7 (CK7), cytokeratin 19 (CK19), cytokeratin 
18 (CK18), epithelial membrane antigen (EMA), 
polyclonal carcinoembryonic antigen (CEA), 
gross cystic disease fluid protein 15 (GCDFP-15), 
CD99 and MUC1 immunostains. They were 
negative for cytokeratin 20 (CK-20), monoclonal 
carcinoembryonic antigen (CEA), CDX-2, pros-
tate-specific antigen (PSA), renal cell carcinoma 
(RCC), PAX8, vimentin, thyroid transcription fac-
tor-1 (TTF-1), hepatocyte specific antigen (Hep 
Par-1), Sal-like protein 4 (SALL4), MUC2, MUC5, 
thyroglobulin, CA19-9, S100 protein, CD34, sur-
factant, estrogen receptor (ER), and factor VIII-re-
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Figure 1. a. orbit MrI coronal view t1; B. t1 post contrast fat 
sat; C. Short tI inversion recovery (StIr); d. axial t1 post con-
trast fat sat. a lobulated mass at left medial canthus invading the 
lacrimal sac and the medial orbital rim. the mass is inseparable 
from anterior eye globe, medial rectus and inferior oblique mus-
cles. the mass is invading the lacrimal sac and the upper part of 
the left nasolacrimal duct
Figure 2. a. orbit Ct with contrast coronal views bone; B. Soft 
tissue (B) windows. a lobulated soft tissue mass (arrow) at left 
medial canthus, invading the left lacrimal sac (a) with focal de-
struction of the lacrimal bone (B)
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lated antigen. These results ruled out systemic me-
tastasis to the orbit or other primary tumors in the 
breast or skin.
Based on all of the above findings, the final 
diagnosis was left orbital primary apocrine ad-
enocarcinoma. Therefore, we proceeded with left 
eyelid-sparing orbital exenteration. Histopathology 
of the left orbit showed moderately differentiated 
apocrine adenocarcinoma with positive margins and 
lymphovascular invasion (pT3bN0). Given these 
high-risk pathological features, the patient was 
given adjuvant chemoradiotherapy; 66 Gray (Gy) 
in 33 fractions to the left socket and intravenous 
Cisplatin. 
Follow up with serial orbit and neck MRI scans, 
showed no local recurrence or regional lymph nodes 
enlargement. The patient has been disease-free for 
the last 5 years with no signs of local or systemic 
recurrence of the tumor.
disCussion
Apocrine adenocarcinoma (AC) is a rare, 
slow-growing skin carcinoma with apocrine dif-
ferentiation arising from apocrine glands. AC oc-
curs most commonly in the axilla followed by 
the anogenital region [4]. These tumors may arise 
rarely in the ocular region, where they are usually 
derived from Moll glands of the eyelid [5]. AC 
should be recognized and treated properly because 
of a high rate of both local recurrence and distant 
metastasis [6].
Kipkie and Haust described the following cri-
teria for the histologic diagnosis of apocrine ad-
enocarcinoma: Periodic acid-Schiff (PAS) positive, 
strongly eosinophilic cytoplasm, decapitation secre-
tion, iron-positive intracellular pigment, and oc-
currence in areas where apocrine glands are nor-
mally located. The PAS-positive malignant apocrine 
epithelial cells often have diastase-resistant granules 
containing iron [7].
Immunohistochemistry has a role in diagnosing 
these tumors, particularly in poorly differentiated 
specimens. GCDFP-15 as a specific tissue marker of 
apocrine epithelium was found to stain apocrine-re-
lated neoplasms in 84% of the specimens [8].
Apocrine adenocarcinoma may represent a pri-
mary skin tumor, or be secondary to various internal 
adenocarcinomas that metastasize to the skin [9]. In 
a major review of 19 cases of AC of the eyelid pub-
lished by Figueira et al., fifty-three percent of cases 
had tumors limited to the eyelids. Most patients 
(18 out of 19) presented with a painless blue-brown 
eyelid lump. Local orbital and periorbital invasion 
was described in 47% of the patients [10]. In a case 
reported by Hoang et al., apocrine adenocarcinoma 
in the lacrimal sac presented as a masquerading 
chronic dacryocystitis [11]. In another case reported 
Figure 3. a. the tumor is composed of well-formed glands, with an irregular lumen and pseudopapillary structures lined by cells with 
abundant acidophilic granular cytoplasm, large vesicular nuclei with single prominent nucleoli. Secretion decapitation at the apical border 
of the tumor cells is seen focally. the lumens contain secretions. In addition, few cells show intracytoplasmic vacuoles containing mucin 
droplets, (H&e X20). B. tumor lymphatic permeation (H&e X40). C. perineural invasion (H&e X40). d. paS/paSD special stain highlighted 
the mucin within the glands and in the cytoplasm of some of the cells (paS/paSD stain, X40)  
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by Shintaku et al., the neoplasm was located in 
the subcutaneous tissue of the eyelid in the medial 
canthus and showed a subconjunctival spread in the 
lacrimal caruncle [12].
In this case report, the patient had no eyelid skin 
mass as is the usual case for these tumors. Instead, 
the tumor occurred primarily in the caruncle with 
local invasion to the lacrimal sac. Given the fact 
that there are no apocrine glands in the lacrimal 
sac region [13], we think that the tumor probably 
originated in the Moll’s gland of the eyelid near 
the region of the medial canthus and subsequently 
exhibited a subconjunctival spread into the lacrimal 
caruncle instead of moving anteriorly toward the 
eyelid skin. This is similar to the case published by 
Shintaku et al. [12] The other possibility is that the 
tumor could have arisen from embryonic epithelial 
remnants within the orbit. 
The possibility of a secondary tumor was ex-
cluded by the normal results of the systemic workup 
and immunohistochemistry. This is consistent with 
the final diagnosis of the presented case as a primary 
apocrine adenocarcinoma of the caruncle with lac-
rimal sac invasion.
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